SALT LAKE CITY, Utah—(BUSINESS WIRE)—Nelson Laboratories, LLC, a Sotera Health company, announced today that it has made significant investments to expand the operations and service capabilities at its Itasca, Illinois laboratory facility to better service customers.
Customers will benefit from the state-of-the-art upgrades to the laboratory facilities as well as 10,000 square feet of building expansion and renovated lab space. Facility upgrades include a world-class BI sterility suite to support EO sterilization validations. Test offerings have been expanded to now include more than double the capacity for bioburden, radiation sterilization validations, bacterial endotoxin testing (BET), and product sterility testing for medical devices and pharmaceutical products.
New testing capabilities will be fully operational beginning May 1, 2018. These capabilities will include medical device particulate testing, healthcare reprocessing validations, sterilization for reuse validations and genetic microbial identification testing.
The Itasca laboratory facility is now ISO 17025 accredited and adheres to the same robust quality system as the Nelson Labs global headquarters in Salt Lake City. Additionally, customers are now able to track their submitted studies and retrieve test reports via the Nelson Labs’ Secure Customer Portal.
“We are very excited about the new and expanded service offerings and laboratory upgrades that are now available at our Itasca facility,” said John S. Bolinder, Vice President of North American lab operations at Nelson Labs. “Our customers will benefit from our enhanced quality system and expanded services, as well as the unparalleled expertise and customer service they have come to trust from Nelson Labs. In addition, we are able to offer the leading sterilization services of our sister company, Sterigenics, at multiple facilities located within close proximity to our Itasca laboratory. This allows us to more fully serve the needs of our sterilization and laboratory customers throughout the Midwestern region of the United States.”
The Nelson Labs Itasca facility will be hosting an open house on May 1, 2018 from 10 a.m. - 2 p.m. Please contact the Itasca facility directly at 630-285-9121 to attend. Customers are invited to tour the facility, learn more about the upgrades and additional test offerings and meet the expert staff.
About Sotera Health: Sotera Health LLC, along with its business entities, is the world’s leading, fully integrated protector of global health. With over 500 years of combined scientific expertise, the company ensures the safety of healthcare by providing mission-critical services to the medical device, pharmaceutical, tissue and food industries. Sotera Health operates more than 61 facilities in 13 countries. The company has over 2,600 employees globally and touches the lives of more than 180 million people around the world each year. Sotera Health serves more than 5,000 customers worldwide including 75 of the top 100 medical device manufacturers.
Sotera Health goes to market through its three best-in-class companies – Nelson Labs™, Nordion® and Sterigenics®, with the mission of ensuring the safety of healthcare each and every day. Nelson Labs offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and the pharmaceutical and biologics fields. Nordion is the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Sterigenics provides comprehensive contract sterilization and ionization solutions for the medical device, pharmaceutical, food safety and high-performance materials industries.
Sotera Health LLC is owned by private equity firms Warburg Pincus and GTCR. Learn more about Sotera Health at soterahealth.com, about Nelson Labs at nelsonlabs.com, about Nordion at nordion.com and about Sterigenics at sterigenics.com.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.